您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2015, Vol. 53 ›› Issue (7): 43-47.doi: 10.6040/j.issn.1671-7554.0.2014.964

• 临床医学 • 上一篇    下一篇

Th22细胞联合Th17细胞在宫颈癌外周血中的表达及意义

田馨莉1, 矫俊1, 张腾1, 马道新2, 崔保霞1   

  1. 1. 山东大学齐鲁医院妇产科,山东 济南 250012;
    2. 山东大学齐鲁医院血液病研究室,山东 济南 250012
  • 收稿日期:2014-12-17 修回日期:2015-03-11 出版日期:2015-07-10 发布日期:2015-07-10
  • 通讯作者: 崔保霞。E-mail:cuibaoxia@sdu.edu.cn E-mail:cuibaoxia@sdu.edu.cn
  • 基金资助:
    国家自然科学基金(81172486);山东大学基本科研业务费(2014QLKY23)

Expression and significance of Th22 and Th17 cells in the peripheral blood of cervical cancer

TIAN Xinli1, JIAO Jun1, ZHANG Teng1, MA Daoxin2, CUI Baoxia1   

  1. 1. Department of Gynecology and Obstetrics, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China;
    2. Institute of Hemopathy, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Received:2014-12-17 Revised:2015-03-11 Online:2015-07-10 Published:2015-07-10

摘要: 目的 探讨宫颈癌外周血中Th22细胞和Th17细胞的表达及其在宫颈癌发生发展中的作用。方法 取34例宫颈癌患者外周血为宫颈癌组、21例宫颈上皮内瘤变(CIN)患者的外周血为CIN组、19例健康志愿者外周血为对照组, 采用流式细胞术检测外周血中Th22、Th17细胞的表达比例。酶联免疫吸附试验(ELISA) 方法检测血浆中相关细胞因子白细胞介素-22(IL-22)的水平。结果 与对照组比较, Th22、Th17细胞比例(占淋巴细胞百分比)CIN组(P<0.01, P<0.05) 及宫颈癌组(P<0.01, P<0.01)均明显升高。Th22细胞比例宫颈癌组又明显高于CIN组(P<0.01)。CIN组中Th22细胞与Th17细胞呈正相关(r=0.41, P<0.05 ), 宫颈癌组Th22细胞与Th17细胞呈正相关(r=0.49, P<0.01)。与对照组相比, IL-22在宫颈癌组外周血中明显升高(P<0.05)。结论 Th22、Th17细胞在宫颈癌患者外周血中比例增高, 在宫颈癌的发生发展中可能起着重要作用。

关键词: 宫颈肿瘤, Th22细胞, 宫颈上皮内瘤变, Th17细胞, 白细胞介素-22

Abstract: Objective To determine the expressions of Th22 and Th17 cells in the peripheral blood of cervical cancer and their contribution in the occurrence and progression of cervical cancer. Methods Flow cytometry was used to determine the percentages of Th22 cells and Th17 cells in the peripheral blood of 34 cervical cancer (CC) patients, 21 cervical intraepithelial neoplasia (CIN) patients and 19 healthy controls. ELISA was adopted to examine the plasma level of interleukin-22(IL-22). Results The percentages of Th22 cells (all P<0.01) and Th17 cells (CIN:P<0.05; CC:P<0.01) in CIN and CC patients were significantly increased compared with those in controls. The percentage of Th22 cells in cervical cancer was higher than that in CIN patients (P<0.01). An positive correlation between Th22 cells and Th17 cells was found in CIN patients (r=0.41, P<0.05). Th22 cells showed a positive correlation with Th17 cells in CC patients (r=0.49, P<0.01). The level of IL-22 in plasma was significantly increased in CC patients compared with that in controls (P<0.05). Conclusion There is a high percentage of Th22 and Th17 cells in CC patients. Th22 and Th17 cells may jointly participate in the pathogenesis and progression of CC.

Key words: Cervical neoplasms, Cervical intraepithelial neoplasia, Th22 cells, Th17 cells, Interleukin-22

中图分类号: 

  • R737.33
[1] Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin, 2005, 55(2):74-108.
[2] Ledwaba T, Dlamini Z, Naicker S, et al. Molecular genetics of human cervical cancer:role of papillomavirus and the apoptotic cascade[J]. Biol Chem, 2004, 385(8):671-682.
[3] Sheu BC, Chang WC, Lin HH, et al. Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia[J]. J Obstet Gynaecol Res, 2007, 33(2):103-113.
[4] Hebner CM, Laimins LA. Humanpapilloma viruses:basic mechanisms of pathogenesis and oncogenicity[J]. Rev Med Virol, 2006, 16(2):83-97.
[5] Kagami S, Rizzo HL, Lee JJ, et al. Circulating Th17, Th22, and Th1 cells are increased in psoriasis[J]. J Invest Dermatol, 2010, 130(5):1373-1383.
[6] Peng D, Xu B, Wang Y, et al. A high frequency of circulating th22 and th17 cells in patients with new onset graves' disease[J]. PloS One, 2013, 8(7):e68446. doi:10.1371/journal.pone.0068446.
[7] Wolk K, Witte E, Witte K, et al. Biology of interleukin-22[J]. Semin Immunopathol, 2010, 32(1):17-31.
[8] Zhang Y, Ma D, Zhang Y, et al. The imbalance of Th17/Treg in patients with uterine cervical cancer[J]. Clin Chim Acta, 2011, 412(11-12):894-900.
[9] Hou F, Li Z, Ma D, et al. Distribution of Th17 cells and Foxp3-expressing T cells in tumor-infiltrating lymphocytes in patients with uterine cervical cancer[J]. Clin Chim Acta, 2012, 413(23-24):1848-1854.
[10] Ryan-Payseur B, Ali Z, Huang D, et al. Virus infection stages and distinct Th1 or Th17/Th22 T-cell responses in malaria/SHIV coinfection correlate with different outcomes of disease[J]. J Infect Dis, 2011, 204(9):1450-1462.
[11] Zhang L, Li YG, Li YH, et al. Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis[J]. PloS One, 2012, 7(4):e31000. doi:10.1371/journal.pone.0031000.
[12] Zhuang Y, Peng LS, Zhao YL, et al. Increased intratumoral IL-22-producing CD4(+) T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival[J]. Cancer Immunol Immunother, 2012, 61(11):1965-1975.
[13] Liu T, Peng L, Yu P, et al. Increased circulating Th22 cells and Th17 cells are associated with tumor progression and patients survival in human gastric cancer[J]. J Clin Immunol, 2012, 32(6):1332-1339.
[14] Qin S, Ma S, Huang X, et al. Th22 cells are associated with hepatocellular carcinoma development and progression[J]. Chin J Cancer Res, 2014, 26(2):135-141.
[15] Ye ZJ, Zhou Q, Yin W, et al. Interleukin 22-producing CD4+ T cells in malignant pleural[J]. Cancer Lett, 2012, 326(1):23-32.
[16] Duhen T, Geiger R, Jarrossay D, et al. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells[J].Nat Immunol, 2009, 10(8):857-863.
[17] 杨佩芳, 付婷, 张建新, 等. 宫颈癌患者外周血和癌组织中Th17细胞水平的变化及其临床意义[J]. 临床检验杂志, 2011, 29(8):586-588. YANG Peifang, FU Ting, ZHANG Jianxin, et al. Detection and significance of TH17 cell in peripheral blood mononuclear cells and cancerous tissue of patients with cervical cancer[J]. Chinese Journal of Clinical Laboratory Science, 2011, 29(8):586-588.
[18] Jiang R, Tan Z, Deng L, et al. Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3[J]. Hepatology, 2011, 54(3):900-909.
[1] 刘京康,杨建勇,孟丽华,姜洁. 血清miR-17-92簇在HPV阳性宫颈癌中的早期诊断价值[J]. 山东大学学报(医学版), 2017, 55(5): 86-90.
[2] 王遥,崔国英,王飞,李长忠. 人类白细胞抗原-E在宫颈癌中的表达及意义[J]. 山东大学学报(医学版), 2016, 54(9): 59-63.
[3] 王雅芬,杨勇霞,刘娅,马德美,朱琳. 宫颈细胞学阴性且高危型人乳头瘤病毒阳性人群的分流方法[J]. 山东大学学报(医学版), 2016, 54(8): 69-71.
[4] 张湛,许相丰,刘海东,王玮. MRI在宫颈癌T分期中的诊断价值[J]. 山东大学学报(医学版), 2016, 54(5): 70-73.
[5] 彭慧,何君梅,苏雪莲. 血清循环miR-375检测对宫颈癌早期诊断及术后监测的意义[J]. 山东大学学报(医学版), 2016, 54(3): 68-71.
[6] 董晓婧,李静,赵蕾,齐眉,孙泽雨,王红,赵蔚明. 鼠衣原体肺部感染中自然杀伤细胞对白细胞介素-22产生及疾病进程的影响[J]. 山东大学学报(医学版), 2016, 54(11): 19-23.
[7] 满琦,张安,张源,樊明德,马道新,王成伟. 脑胶质瘤患者外周血中Th17、Th22细胞的表达及意义[J]. 山东大学学报(医学版), 2016, 54(10): 55-59.
[8] 白金霞, 白金运, 石秀菊, 许洪伟. IL-22介导的STAT3信号通路对急性重症胰腺炎小鼠的保护作用[J]. 山东大学学报(医学版), 2015, 53(6): 1-6.
[9] 张荣军, 韩波, 高聆, 朱梅, 丁国玉, 梁燕. siRNA沉默CD40基因对实验性自身免疫性心肌炎大鼠的作用及IL-22表达的影响[J]. 山东大学学报(医学版), 2015, 53(5): 36-40.
[10] 刘亚飞, 张奇舒, 袁首道, 陈健行. HPV永生化细胞系与SiHa细胞系蛋白质表达差异的质谱分析[J]. 山东大学学报(医学版), 2015, 53(3): 22-26.
[11] 李晨, 程玉峰, 李爱禄. 妇科门诊女性人乳头瘤病毒感染型别分布特征及临床分析[J]. 山东大学学报(医学版), 2015, 53(11): 73-76.
[12] 宗丽菊, 张友忠, 王颉, 吴淑霞, 刘洪丽, 张璐. 四甲基吡啶卟啉-光动力疗法对人宫颈永生化上皮H8细胞的作用[J]. 山东大学学报(医学版), 2015, 53(1): 21-26.
[13] 王颉, 张友忠, 冯进波, 刘洪丽, 宗丽菊. 慢病毒介导的hTERT-shRNA联合光动力治疗对宫颈癌细胞SiHa的影响[J]. 山东大学学报(医学版), 2015, 53(1): 27-33.
[14] 张演亮1,庄子荣2,朱琳1,梁婷婷1. 宫颈癌患者腹腔镜术后生存质量调查[J]. 山东大学学报(医学版), 2014, 52(6): 62-66.
[15] 张璐,颜磊,张辉,张晓晖,李明江,赵兴波. 精子相关抗原9在宫颈癌及宫颈上皮内瘤变中的表达及意义[J]. 山东大学学报(医学版), 2014, 52(6): 67-71.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!